REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Biospifar S A (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Biospifar S A Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Comercio al por mayor de productos farmaceuticos, medicinales, cosmeticos y de tocador.comercio al por mayor de equipos medicos y quirurgicos y de aparatos ortesicos y protesicos.

Headquarters
Avenida Carrera 7 155 80 Interior 7 Oficina 115 Edificio North Point Office
Bogota D.C.; Bogota D.C; Postal Code: 1007

Contact Details: Purchase the Biospifar S A report to view the information.

Basic Information
Total Employees:
Purchase the Biospifar S A report to view the information.
Outstanding Shares:
Purchase the Biospifar S A report to view the information.
Incorporation Date:
December 15, 2004
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Biospifar S A report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
5.31%▲
Total operating revenue
5.64%▲
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
10.64%▲
Total equity
11.99%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
0%
Quick Ratio
0.45%▲
Cash Ratio
-0.11%▼

Similar companies

Audifarma S.A.
 
Cooperativa Nacional de Droguistas Detallistas
Tecnoquimicas S.A.
 
Unilever Andina Colombia Ltda
Bel-Star S.A.
 
Procaps S.A.
Intersurgical S.A.S.
 
Cvs S.A.S.
Miis Cosmetics S.A.S
 
Farmacos de la Costa Ltda
Representaciones Farmaceuticas Galex S.A.S.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo